A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Marijuana and its CD4 Receptors: A New HIV Treatment Strategy?
Pathway to a Cure: Cancer Drug Helps Purge HIV From Resting Cells
Life Expectancy With HIV Increases Dramatically
Undetectable Viral Load? Not Necessarily in Semen
Engineering CD8 Cells to Kill HIV in Tissues
Pathway to a Cure: Positive Results Continue for Sangamo's CCR5 Gene Therapy
Revised U.S. Guidelines: HIV Treatment is Recommended for All People Living With HIV
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailprint

October 1, 2009

Many Prisoners Revert to Intermittent Treatment After Incarceration

Less than 17 percent of HIV-positive inmates on antiretroviral (ARV) therapy continue taking their treatment consistently once they are released from prison, according to a study published September 22 in the online journal PLoS One.

Though there are often still many barriers to effective HIV therapy in prison, researchers have known that some incarcerated people are better able to access and adhere to ARV treatment while in prison than after they are released. Potential reasons for this include lack of housing, employment, access to care and social support.

To determine the rate of continuous HIV treatment after release from prison, Nitika Pant Pai, MD, from the McGill University Health Center in Montreal, and her colleagues studied 512 HIV-positive individuals doing repeated stints in the San Francisco County jail system. The study was conducted during a nine-year period.

Seventy-six percent of the study participants reported taking their HIV medications only intermittently between sentences or after leaving prison. Fifteen percent reported using their ARVs continuously, and 9 percent were never on therapy at all. Of the 497 who were on treatment for at least some period during the study, 16.9 percent remained on treatment continuously.

“The optimal solution for treating patients and controlling the HIV epidemic in the USA is to ensure continuous therapy,” claimed Milton Estes, MD, medical director of Forensic AIDS Project, San Francisco, in a press release from McGill University. “To achieve this we must work on various aspects of the prisoners’ lives, such as marginalization, psychiatric problems and drug use, both before and after their departure from prison.”

Jacqueline Tulsky, MD, from the University of California at San Francisco and a coauthor of the study, concludes, “This research highlights the need to examine ARV policies inside and outside correctional settings with a view to establishing effective lifelong management of HIV in prisoners.”

Search: Prison, incarceration, prisoner, adherence, treatment continuity, Nitika Pant Pai, Milton Estes, Jacqueline Tulsky


Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    charliehunter
    San Francisco
    California


    sequoiamv
    San Jose
    California


    sable22
    Orlando
    Florida


    gbc1971
    macon
    Georgia
Click here to join POZ Personals!
Conference Coverage

19th Conference on Retroviruses and Opportunistic Infections (CROI 2012)
Seattle, Washington
March 5 - 8, 2012


6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.